Close Menu
Home › Paradigm Diagnostics Raises Additional $3M in Series B Round

Paradigm Diagnostics Raises Additional $3M in Series B Round

Feb 16, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Paradigm Diagnostics announced today that it has secured an additional $3 million in funding as part of a planned $7 million Series B round of financing.

The investment was made by New Science Ventures and follows a $3.5 million investment led by Mesa Verde Venture Partners in November. New Science Ventures Partner Grace Colón also joined Paradigm's board.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
10
Featured Webinar

Maximizing Diagnostic Yield with an Optimized Variant Interpretation Platform

Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

What's Popular?

In Sequencing

  1. Adaptive Biotechnologies Q3 Revenues Rise 52 Percent

  2. Fulgent Genetics Prices $26.2M Public Stock Offering

  3. Curetis Posts 17 Percent Increase in Preliminary Revenues for First Nine Months of 2019

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.